Aussie MD's next big role revealed

Posted 6 June, 2024 PM 

ASX-listed Genetic Signatures has nabbed Managing Director of Roche Diagnostics Allison Rossiter as its next CEO hot on the heels of announcing FDA clearance for entry into the US market.

The molecular diagnostics company described the appointment as "momentous" with eager plans to tap into Rossiter's extensive global experience. In her high-flying 22-year career at Roche, Rossiter has worked in Europe, North America and most recently, five years in Australia.

To see the whole article, please login